| Issue Date | Title | Author(s) |
| 2022-06-15 | Current Issues in Health Technology Assessment of Cancer Therapies: A Survey of Stakeholders and Opinion Leaders in Australia. | Kim, H; Liew, D; Goodall, S |
| 2022-08 | An examination of machine learning to map non-preference based patient reported outcome measures to health state utility values. | Aghdaee, M; Parkinson, B; Sinha, K; Gu, Y; Sharma, R; Olin, E; Cutler, H |
| 2022-04 | Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB. | Peasgood, T; Mukuria, C; Brazier, J; Marten, O; Kreimeier, S; Luo, N; Mulhern, B; Greiner, W; Pickard, AS; Augustovski, F; Engel, L; Gibbons, L; Yang, Z; Monteiro, AL; Kuharic, M; Belizan, M; Bjørner, J |
| 2022-08 | Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia. | Song, R; Jeet, V; Sharma, R; Hoyle, M; Parkinson, B |
| 2022-04 | The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results. | Brazier, J; Peasgood, T; Mukuria, C; Marten, O; Kreimeier, S; Luo, N; Mulhern, B; Pickard, AS; Augustovski, F; Greiner, W; Engel, L; Belizan, M; Yang, Z; Monteiro, A; Kuharic, M; Gibbons, L; Ludwig, K; Carlton, J; Connell, J; Rand, S; Devlin, N; Jones, K; Tsuchiya, A; Lovett, R; Naidoo, B; Rowen, D; Rejon-Parrilla, JC |
| 2022-04 | Generation, Selection, and Face Validation of Items for a New Generic Measure of Quality of Life: The EQ-HWB. | Carlton, J; Peasgood, T; Mukuria, C; Connell, J; Brazier, J; Ludwig, K; Marten, O; Kreimeier, S; Engel, L; Belizán, M; Yang, Z; Monteiro, A; Kuharic, M; Luo, N; Mulhern, B; Greiner, W; Pickard, S; Augustovski, F |
| 2022-10-31 | Re-Thinking Felid–Human Entanglements through the Lenses of Compassionate Conservation and Multispecies Studies | Steinhardt, M; Pratt, S; Ramp, D |
| 2022 | Learning at the Intersection of Data Literacy and Social Justice | Knight, S; Matuk, C; DesPortes, K |
| 2022-10 | Preferences for a polygenic test to estimate cancer risk in a general Australian population. | Venning, B; Saya, S; De Abreu Lourenco, R; Street, DJ; Emery, JD |
| 2022-10-21 | Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement. | Gye, A; Goodall, S; De Abreu Lourenco, R |
